The inquiry upon the manner in which THC produces its psychoactive effects on the human body led, in the 1980’s, to the discovery of the endocannabinoid system – a rather loose complex of nerve receptors which under the influence of compounds called cannabinoids trigger many physiological and psychological reactions. Because cannabinoid receptors are present in almost every tissue of a mammal’s body (although they are not limited to mammals), it has wide-ranging influences on the well-being of an organism. Therefore cannabinoids are definitely substances that deserve further attention from scientists.
Also listed among our low potency products is our bestselling CanChew® gum. With just 10 mg of CBD per piece of gum, it is easy to get started with CBD as a supplement, and adding more CBD to your diet is as simple as chewing another piece of gum. Another approachable product for those just starting out with CBD, CanChew® gum is a simple delivery method for getting your daily CBD.
It’s believed that while CBD helps activate and regulate the body’s endocannabinoid system, it also helps regulate the neural pathways that are responsible for withdrawal symptoms and drug cravings. In early rat trials, those treated with CBD were less likely to exhibit anxiety-related withdrawal symptoms and drug-seeking behaviors after being exposed to cocaine. (40)
Customer Service: We’ve always received fast, informative responses to our queries about products and practices, but there are definitely customers out there who have not. A quick perusal of reviews shows customers who had issues with unaddressed orders. It’s hard to know exactly what the problem is in these situations, but the company’s strict return policy (seven days for unopened products only) probably doesn’t help. It should be noted that the company has a solid base of very satisfied customers as well.
At this time, there does seem to be a growing body of basic pharmacologic data suggesting there may be a role for CBD, especially in the treatment of refractory epilepsy. However, given the lack of well-controlled trials, we must also ask if we are getting ahead of ourselves. Clearly, this is an emotionally and politically charged issue. If this were any other uninvestigated pharmaceutical compound, would we feel as compelled to make the agent widely available before statistically valid class 1 evidence was available for review? Until data from well-designed clinical trials are available and reliable, and standardized CBD products that are produced using GMP are available, caution must be exercised in any consideration of using CBD for the treatment of epilepsy. In the meantime, based upon promising preliminary data, further clinical research should be wholeheartedly pursued.
Unlike acute inflammation, chronic inflammation is long-term and on-going. When your body is experiencing excessive – physical, emotional, or chemical – stress load, it ends up feeling like that there is danger all the time. It thinks that it needs to defend you constantly, thus becomes overwhelmed. This chronic inflammatory stimulus results in an increased and ongoing inflammatory response, chronic inflammation, and often chronic pain.
A number of difficulties exist in evaluating published data on CBD or marijuana use for epilepsy. The extremely limited published studies were small, poorly described, and not well designed. Contributing to the difficulty of interpreting published studies, CBD products are not produced under the guidance of good manufacturing practices (GMP) and are not subject to regulations governing labeling, purity, and reliability. In other words, currently, there is no guarantee of consistency between products, or even differing lots produced by the same manufacturer. Without independent testing (e.g. USP certification) of CBD products for content and purity, as well as bioavailability testing of specific products, uncertainty surrounds the use of available CBD products in routine clinical settings.
This is why Amanda Oliver, 31, a career consultant in Charleston, SC, pops a CBD gummy bear each night before bed. “I used to lie there tossing and turning as my mind raced from work projects to whether I had set the home alarm,” Oliver says. One piece of candy with 15 milligrams (mg) of CBD is enough to shut off her brain and facilitate sleep. She also swears by the CBD oil she takes at the height of her period, which she says quells her debilitating cramps.
A common misconception we hear is “cannabinoids from hemp are not as good as cannabinoids from cannabis.” This statement is arguably confusing; hemp is cannabis, just like all the other strains that fall under the cannabis species. They variations of cannabinoids they can contain are endless — you never know what they have until the oil is extracted and tested. Our properly sourced hemp oil is rich in their proprietary cannabinoid blend and is 3rd party lab tested to verify cannabinoid potency and to check for any contaminants.
By commenting on this post I agree to give source information for any health/medical information that is not my personal experience or general knowledge. I understand that personal experience is any symptom, test, treatment, etc. that I or a close family member has undergone himself/herself. I understand that my comment will not be approved unless I provide trustworthy sources for all statements regarding statistics, data, studies, and new advancement in medicine.
According to the largest study to date, researchers reported that after treating 162 patients with an extract of 99% cannabidiol (CBD), for a 12 week period. the intervention reduced motor seizures at a rate similar to existing drugs ( a median of 36.5 percent) and 2% of patients became completely seizure free. Other studies have shown that it can act as an anticonvulsant.
Over the past few years, increasing public and political pressure has supported legalization of medical marijuana. One of the main thrusts in this effort has related to the treatment of refractory epilepsy—especially in children with Dravet syndrome—using cannabidiol (CBD). Despite initiatives in numerous states to at least legalize possession of CBD oil for treating epilepsy, little published evidence is available to prove or disprove the efficacy and safety of CBD in patients with epilepsy. This review highlights some of the basic science theory behind the use of CBD, summarizes published data on clinical use of CBD for epilepsy, and highlights issues related to the use of currently available CBD products.
It’s thought that the endocannabinoid system may be critical for regulating sleep and sleep stability, which make sense, as it promotes balance throughout the body. Research seems to show that when CBD interacts with this system, sufferers may achieve longer periods of overall sleep. Furthermore, earlier research demonstrated that CBD may provide relief for insomnia sufferers who struggle to achieve REM sleep due to anxiety. (33, 34, 35)
Now, as far as migraines cured I am using it also to help with my nerve pain from my spine and waiting to see if it helps my asthma. I have gone from 12 Gabapentins a day to 4-6. I’m hoping it worx for asthma. I have started taking it twice a day for the last 3 days and being in cold rainy damp weather with all the flowers and trees in bloom on top of my allergies I am hoping this CBD helps asthma to.

Another field in which CBD is creating a buzz is in the area of mood disorders like anxiety and depression. Both conditions have been treated with a variety of medications, courtesy of Big Pharma, that have had varying levels of success. Again, the long list of side effects can be off-putting to someone who just wants to get through the day without the sweaty tension of anxiety or the gray haze of depression.

×